文献速递脑血管病

直接口服抗凝药治疗期间脑缺血的临床特征

Cerebral Ischemia in Patients on Direct Oral Anticoagulants.
PubMed 文献 · Stroke · 2019-01-01

研究发现入院时DOAC血浆水平低与更高的NIHSS评分、大血管闭塞风险及持续神经功能缺损或影像学脑梗死相关。

要点

  • 入院时DOAC血浆水平低与更高的NIHSS评分相关。
  • 低DOAC血浆水平是大血管闭塞的独立预测因素(OR 3.84,95%CI 1.80-8.20,P=0.001)。
  • 低DOAC血浆水平与持续神经功能缺损或影像学脑梗死风险更高相关。

核心结论

  • 入院时通过特定DOAC血浆水平测定的抗凝活性与卒中严重程度及大血管闭塞存在关联。

主要发现

  • 维生素K拮抗剂患者中,入院INR低于1.7者NIHSS评分更高且大血管闭塞风险更高。
  • DOAC患者中75.6%有血浆水平数据,低水平(<50 ng/mL)49例(27.7%),中水平(50-100 ng/mL)41例(23.2%),高水平(>100 ng/mL)87例(49.2%)。
  • 低DOAC血浆水平组入院NIHSS评分为8(四分位距3-15),中水平组为4(1-11),高水平组为3(0-8),P<0.001。
  • 低DOAC血浆水平组持续神经功能缺损或影像学脑梗死比例为85.7%,中水平组为75.6%,高水平组为54.0%,P<0.001。
  • 低DOAC血浆水平是大血管闭塞的独立预测因素(OR 3.84,95%CI 1.80-8.20,P=0.001)。

关键数值与推荐

  • 维生素K拮抗剂活性以入院INR评估,以1.7为阈值分类。
  • DOAC血浆水平通过校准Xa活性(阿哌沙班、利伐沙班、依度沙班)或Hemoclot试验(达比加群)测定,分为低(<50 ng/mL)、中(50-100 ng/mL)、高(>100 ng/mL)。

临床怎么用

  • 对服用DOAC期间发生急性脑缺血的患者,入院时测定DOAC血浆水平可能有助于评估卒中严重程度和大血管闭塞风险。

局限性

  • DOAC血浆水平数据仅在75.6%的患者中可用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- In patients with ischemic stroke on therapy with vitamin K antagonists, stroke severity and clinical course are affected by the quality of anticoagulation at the time of stroke onset, but clinical data for patients using direct oral anticoagulants (DOACs) are limited. Methods- Data from our registry including all patients admitted with acute cerebral ischemia while taking oral anticoagulants for atrial fibrillation between November 2014 and October 2017 were investigated. The activity of vitamin K antagonists was assessed using the international normalized ratio on admission and categorized according to a threshold of 1.7. DOAC plasma levels were measured using the calibrated Xa-activity (apixaban, rivaroxaban, and edoxaban) or the Hemoclot-assay (dabigatran) and categorized into low (<50 ng/mL), intermediate (50-100 ng/mL), or high (>100 ng/mL). Primary objective was the association between anticoagulant activity and clinical and imaging characteristics. Results- Four hundred sixty patients were included (49% on vitamin K antagonists and 51% on DOAC). Patients on vitamin K antagonists with low international normalized ratio values had higher scores on the National Institutes of Health Stroke Scale and a higher risk of large vessel occlusion on admission. For patients on DOAC, plasma levels were available in 75.6% and found to be low in 49 (27.7%), intermediate in 41 (23.2%), and high in 87 patients (49.2%). Low plasma levels were associated with higher National Institutes of Health Stroke Scale scores on admission (low: 8 [interquartile range, 3-15] versus intermediate: 4 [1-11] versus high: 3 [0-8]; P<0.001) and higher risk of persisting neurological deficits or cerebral infarction on imaging (85.7% versus 75.6% versus 54.0%; P<0.001). Low DOAC plasma levels were an independent predictor of large vessel occlusion (odds ratio, 3.84 [95% CI, 1.80-8.20]; P=0.001). Conclusions- The activity of anticoagulation measured by specific DOAC plasma levels on admission is associated with stroke severity and presence of large vessel occlusion.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Macha K, Marsch A, Siedler G, et al. Cerebral Ischemia in Patients on Direct Oral Anticoagulants. Stroke. 2019. PMID: 30852963. doi:10.1161/STROKEAHA.118.023877

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。